ALK and non-small cell lung carcinoma: In fact, recent discoveries pointed out the immunological properties of therapeutic strategies against ALK, such as ALK peptide vaccination in NSCLC and chimeric antigen receptor (CAR)-T cell therapy against ALK in neuroblastoma [43,44].